Drug index

Back to Top
The purpose of this page is to provide a quick lookup of drugs by different categorizations. In the first several sections, drugs are listed in alphabetical order and organized by whether they are anticancer ("antineoplastic") or supportive. Supportive medications include those intended to ameliorate the side effects of anticancer treatments, as well as a substantial number of medications used to treat classical blood disorders. Drugs are additionally categorized by whether they are approved (by any regulator, not just the FDA), investigational, or discontinued. We also call out recent approvals (within the current or prior calendar year) with a bolded tag for quick discovery.
=Guidelines=
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.
Other interesting and helpful links can be found by clicking the link.
==Chemotherapy safety standards==
*2020: Dillmon et al. Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards EuroPMC
*2019: Celano et al. Safe handling of hazardous drugs: ASCO standards EuroPMC
*2016: Neuss et al. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology
*2010: Carrington et al. The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy EuroPMC
==Dose adjustments==
*2021: Griggs et al. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update
*2012: Griggs et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology Clinical Practice GuidelineGriggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. link to original article EuroPMC
==Antimicrobials==
*2013: Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology Clinical Practice Guideline
==Growth factors==
*2015: Update of ASCO Clinical Practice Guideline recommendations for the use of WBC growth factorsSmith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015 Oct 1;33(28):3199-212. Epub 2015 Jul 13. link to original article EuroPMC
=Approved antineoplastics=
This section contains anticancer drugs that have had at least one formal approval in any domain (FDA, EMA, etc). Biosimilars are also indexed here, indented below their parent compound. Note that EMA biosimilar approvals do not include the four-letter suffix at this time, which we have added to distinguish the generic ingredient from the parent compound. For drugs first approved within the current or prior calendar years, the date of initial approval is also provided here.
==A==
*Abarelix (Plenaxis)
*Abemaciclib (Verzenio)
*Abiraterone (Zytiga)
*Acalabrutinib (Calquence)
*Aclarubicin (Aclacinomycin)
*Adagrasib (Krazati)
*Afamitresgene Autoleucel (Tecelra) FDA approved 2024-08-02
*Afatinib (Gilotrif)
*Aldesleukin (Proleukin)
*Alectinib (Alecensa)
*Alemtuzumab (Campath)
*Alitretinoin (Panretin)
*All-trans retinoic acid (ATRA)
*Alpelisib (Piqray)
*Altretamine (Hexalen)
*Alvocidib (Flavopiridol)
*Amifostine (Ethyol)
*Aminoglutethimide (Cytadren)
*Amivantamab (Rybrevant)
*Amrubicin (Calsed)
*Amsacrine (Amsidine)
*Anastrozole (Arimidex)
*Ancestim (Stemgen)
*Anlotinib (Fukewei)
*Apalutamide (Erleada)
*Apatinib (Aitan)
*Arsenic trioxide (Trisenox)
*Asciminib (Scemblix)
*Asparaginase Erwinia chrysanthemi (Erwinaze)
**Asparaginase erwinia chrysanthemi-rywn (Rylaze)
*Atezolizumab (Tecentriq)
**Atezolizumab and hyaluronidase (Tecentriq Hybreza) FDA approved 2024-09-12
*Aumolertinib (Amelie)
*Avapritinib (Ayvakit)
*Avelumab (Bavencio)
*Axicabtagene ciloleucel (Yescarta)
*Axitinib (Inlyta)
*Azacitidine (Onureg)
*Azacitidine (Vidaza)
==B==
*BCG vaccine
*Belantamab mafodotin (Blenrep)
*Belinostat (Beleodaq)
*Belotecan (Camptobell)
*Belumosudil (Rezurock)
*Belzutifan (Welireg)
*Bendamustine
*Benralizumab (Fasenra)
*Bevacizumab (Avastin)
**Bevacizumab-adcd (Vegzelga)
**Bevacizumab-aveg (Avegra)
**Bevacizumab-awwb (Mvasi)
**Bevacizumab-aybi (Aybintio)
**Bevacizumab-bvzr (Zirabev)
**Bevacizumab-byva (Byvasda)
**Bevacizumab-equi (Equidacent)
**Bevacizumab-maly (Alymsys)
**Bevacizumab-onbe (Onbevzi)
**Bevacizumab-tnjn (Avzivi)
*Bexarotene (Targretin)
*Bicalutamide (Casodex)
*Binimetinib (Mektovi)
*Bleomycin (Blenoxane)
*Blinatumomab (Blincyto)
*Borofalan-10B (Steboronine)
*Bortezomib (Velcade)
*Bosutinib (Bosulif)
*Brentuximab vedotin (Adcetris)
*Brexucabtagene autoleucel (Tecartus)
*Brigatinib (Alunbrig)
*Buserelin (Suprefact)
*Busulfan (Myleran)
==C==
*Cabazitaxel (Jevtana)
*Cabozantinib (Cabometyx)
*Cabozantinib (Cometriq)
*Cadonilimab (AK-104)
*Calaspargase (Asparlas)
*Camrelizumab (AiRuiKa)
*Capecitabine (Xeloda)
*Capivasertib (Truqap)
*Caplacizumab (Cablivi)
*Capmatinib (Tabrecta)
*Carboplatin (Paraplatin)
*Carfilzomib (Kyprolis)
*Carmofur (HCFU)
*Carmustine (BCNU)
*Carmustine wafer, polifeprosan 20 (Gliadel)
*Cemiplimab (Libtayo)
*Ceritinib (Zykadia)
*Cetuximab (Erbitux)
**Cetuximab-cetu (Cetuxa)
*Chidamide (Epidaza)
*Chlorambucil (Leukeran)
*Chlorozotocin (DCNU)
*Ciltacabtagene autoleucel (Carvykti)
*Cisplatin (Platinol)
*Cladribine (Leustatin)
*Clofarabine (Clolar)
*Cobimetinib (Cotellic)
*Copanlisib (Aliqopa)
*Cortisone
*Cosibelimab (Unloxcyt) FDA approved 2024-12-13
*Crizotinib (Xalkori)
*Cyclophosphamide (Cytoxan)
*Cyproterone acetate (Androcur)
*Cytarabine (Ara-C)
*Cytarabine and daunorubicin liposomal (Vyxeos)
*Cytarabine liposomal (DepoCyt)
==D==
*Dabrafenib (Tafinlar)
*Dacarbazine (DTIC)
*Dacomitinib (Vizimpro)
*Dactinomycin (Cosmegen)
*Daratumumab (Darzalex)
**Daratumumab and hyaluronidase (Darzalex Faspro)
**Daratumumab and vorhyaluronidase (Darzquro)
*Darinaparsin (Darvias)
*Darolutamide (Nubeqa)
*Dasatinib (Sprycel)
*Datopotamab deruxtecan (Datroway) FDA approved on 2025-01-17
*Daunorubicin (Cerubidine)
*Decitabine (Dacogen)
*Decitabine and cedazuridine (Inqovi)
*Degarelix (Firmagon)
*Dexamethasone (Decadron)
*Dinutuximab (Unituxin)
*Dinutuximab beta (Qarziba)
*Docetaxel (Taxotere)
*Donafenib (Zepsun)
*Dostarlimab (Jemperli)
*Doxifluridine (Didox)
*Doxorubicin (Adriamycin)
*Durvalumab (Imfinzi)
*Dutasteride (Avodart)
*Duvelisib (Copiktra)
==E==
*Eflornithine (Iwilfin)
*Elacestrant (Orserdu)
*Elotuzumab (Empliciti)
*Elranatamab (Elrexfio)
*Emapalumab (Gamifant)
*Enasidenib (Idhifa)
*Encorafenib (Braftovi)
*Enfortumab vedotin (Padcev)
*Ensartinib (Ensacove)
*Entinostat (Jingzhuda) NMPA approved 2024-04-24
*Entrectinib (Rozlytrek)
*Envafolimab (Enweida)
*Enzalutamide (Xtandi)
*Epcoritamab (Epkinly)
*Epirubicin (Ellence)
*Erdafitinib (Balversa)
*Eribulin (Halaven)
*Erlotinib (Tarceva)
*Estradiol
*Estramustine (Emcyt)
*Etoposide (Vepesid)
*Everolimus (Afinitor)
*Exemestane (Aromasin)
==F==
*Fadrozole (Afema)
*Fedratinib (Inrebic)
*Fluorouracil (5-FU)
*Fludarabine (Fludara)
*Flumatinib (Xinfu)
*Flutamide (Eulexin)
*Leucovorin (Folinic acid)
*Forodesine (Fodosine)
*Fostamatinib (Tavalisse)
*Fotemustine (Muphoran)
*Fruquintinib (Elunate)
*Fulvestrant (Faslodex)
*Furmonertinib (Ivesa)
*Futibatinib (Lytgobi)
==G==
*Gallium Ga 68 gozetotide (Locametz)
*Gefitinib (Iressa)
*Gemcitabine (Gemzar)
*Gemtuzumab ozogamicin (Mylotarg)
*Gilteritinib (Xospata)
*Glasdegib (Daurismo)
*Glofitamab (Columvi)
*Goserelin (Zoladex)
==H==
*Heptaplatin (SunPla)
*Histamine dihydrochloride (Ceplene)
*Histrelin (Vantas)
*Hydrocortisone (Cortef)
*Hydroxyurea (Hydrea)
==I==
*Ibritumomab tiuxetan (Zevalin)
*Ibrutinib (Imbruvica)
*Icotinib (Conmana)
*Idarubicin (Idamycin)
*Idecabtagene vicleucel (Abecma)
*Idelalisib (Zydelig)
*Ifosfamide (Ifex)
*Imatinib (Gleevec)
*Imetelstat (Rytelo) FDA approved 2024-06-06
*Inavolisib (Itovebi) FDA approved 2024-10-10
*Infigratinib (Truseltiq)
*Inotuzumab ozogamicin (Besponsa)
*Interferon alfa-2a (Roferon-A)
*Interferon alfa-2b (Intron-A)
*Interferon gamma-1a (Imunomax-γ)
*Interferon gamma-1b (Actimmune)
*Iobenguane I 131 (Azedra)
*Iodine-131
*Ipilimumab (Yervoy)
*Irinotecan (Camptosar)
*Irinotecan liposome (Onivyde)
*Isatuximab (Sarclisa)
*Isotretinoin (Accutane)
*Ivonescimab (Akeso) NMPA approved 2024-05-24
*Ivosidenib (Tibsovo)
*Ixabepilone (Ixempra)
*Ixazomib (Ninlaro)
==K==
*Ketoconazole (Nizoral)
==L==
*Lanreotide (Somatuline)
*Lanreotide LAR (Somatuline Depot)
*Lapatinib (Tykerb)
*Larotrectinib (Vitrakvi)
*Lasofoxifene (Fablyn)
*Lenalidomide (Revlimid)
*Lenvatinib (Lenvima)
*Letrozole (Femara)
*Leuprolide (Lupron)
*Levoleucovorin (Fusilev)
*Lifileuecel (Contego) FDA approved 2024-02-16
*Lisocabtagene maraleucel (Breyanzi)
*Lobaplatin (D-19466)
*Lomustine (CCNU)
*Loncastuximab tesirine (Zynlonta)
*Lorlatinib (Lorbrena)
*Lurbinectedin (Zepzelca)
*Lutetium Lu 177 dotatate (Lutathera)
*Lutetium Lu 177 vipivotide tetraxetan (Pluvicto)
==M==
*Margetuximab (Margenza)
*Mechlorethamine (Mustargen)
*Medroxyprogesterone acetate (MPA)
*Megestrol (Megace)
*Melphalan (Alkeran)
*Melphalan for Injection-Hepatic Delivery System (Hepzato Kit)
*Mepolizumab (Nucala)
*Mercaptopurine (6-MP)
*Methotrexate (MTX)
*Methoxsalen (Uvadex)
*Methylprednisolone (Solumedrol)
*Midostaurin (Rydapt)
*Mifamurtide (Mepact)
*Miriplatin (Miripla)
*Mirvetuximab soravtansine (Elahere)
*Mitomycin pyelocalyceal (Jelmyto)
*Mitomycin (Mutamycin)
*Mitotane (Lysodren)
*Mitoxantrone (Novantrone)
*Mobocertinib (Exkivity)
*Mogamulizumab (Poteligeo)
*Momelotinib (Ojjaara)
*Mosunetuzumab (Lunsumio)
*Moxetumomab pasudotox (Lumoxiti)
==N==
*Nadofaragene firadenovec (Adstiladrin)
*Naxitamab (Danyelza)
*Necitumumab (Portrazza)
*Nedaplatin (Aqupla)
*Nelarabine (Arranon)
*Neratinib (Nerlynx)
*Nilotinib (Tasigna)
*Nilutamide (Nilandron)
*Nimotuzumab (Theraloc)
*Nimustine (ACNU)
*Nintedanib (Vargatef)
*Niraparib (Zejula)
*Niraparib and abiraterone (Akeega)
*Nirogacestat (Ogsiveo)
*Nivolumab (Opdivo)
*Nivolumab and hyaluronidase (Opdivo Qvantig) FDA approved 2024-12-27
*Nivolumab and relatlimab (Opdualag)
*Nogapendekin alfa inbakicept (Anktiva) FDA approved 2024-04-22
*Non-pegylated liposomal doxorubicin (Myocet)
*Norethandrolone (Nilevar)
*NovoTTF-100A system (Optune)
==O==
*Obecabtagene autoleucel (Aucatzyl) FDA approved 2024-11-08
*Obinutuzumab (Gazyva)
*Octreotide (Sandostatin)
*Octreotide LAR (Sandostatin LAR)
*Ofatumumab (Arzerra)
*Olaparib (Lynparza)
*Olutasidenib (Rezlidhia)
*Olverembatinib (HQP-1351)
*Omacetaxine (Synribo)
*Osimertinib (Tagrisso)
*Oxaliplatin (Eloxatin)
==P==
*Paclitaxel (Taxol)
*Paclitaxel, nanoparticle albumin-bound (Abraxane)
*Paclitaxel, polymeric micelle-bound (Genexol-PM)
*Pacritinib (Vonjo)
*Padeliporfin (Tookad)
*Palbociclib (Ibrance)
*Panitumumab (Vectibix)
*Panobinostat (Farydak)
*Pazopanib (Votrient)
*Pegaspargase (Oncaspar)
*Peginterferon alfa-2a (Pegasys)
*Peginterferon alfa-2b (Sylatron)
*Pegylated liposomal doxorubicin (Doxil)
*Pembrolizumab (Keytruda)
*Pemetrexed (Alimta)
*Pemigatinib (Pemazyre)
*Penpulimab (Anniko)
*Pentostatin (Nipent)
*Pertuzumab (Perjeta)
*Pertuzumab and Trastuzumab hyaluronidase (Phesgo)
*Pexidartinib (Turalio)
*Pipobroman (Vercyte)
*Pirarubicin (THP)
*Pirtobrutinib (Jaypirca)
*Pixantrone (Pixuvri)
*Polatuzumab vedotin (Polivy)
*Pomalidomide (Pomalyst)
*Ponatinib (Iclusig)
*Porfimer (Photofrin)
*Pralatrexate (Folotyn)
*Pralsetinib (Gavreto)
*Prednisone (Sterapred)
*Prednisolone (Millipred)
*Procarbazine (Matulane)
*Pyrotinib (Irene)
==Q==
*Quizartinib (Vanflyta)
==R==
*Racotumomab (Vaxira)
*Radium-223 (Xofigo)
*Radotinib (Supect)
*Raltitrexed (Tomudex)
*Ramucirumab (Cyramza)
*Ranimustine (Cymerin)
*Ravulizumab (Ultomiris)
*Realgar-Indigo naturalis formulation
*Regorafenib (Stivarga)
*Relugolix (Orgovyx)
*Repotrectinib (Augtyro)
*Retifanlimab (Zynyz)
*Revumenib (Revuforj) FDA approved 2024-11-15
*Rezvilutamide (Ariane)
*Ribociclib (Kisqali)
*Ripretinib (Qinlock)
*Rituximab (Rituxan)
**Rituximab-abbs (Truxima)
**Rituximab-arrx (Riabni)
**Rituximab-pvvr (Ruxience)
**Rituximab-blit (Blitzima)
**Rituximab-rite (Ritemvia)
**Rituximab-rixa (Rixathon)
**Rituximab-rixi (Riximyo)
**Rituximab and hyaluronidase human (Rituxan Hycela)
*Romidepsin (Istodax)
*Ropeginterferon alfa-2b (Besremi)
*Rucaparib (Rubraca)
*Ruxolitinib (Jakafi)
==S==
*Sacituzumab govitecan (Trodelvy)
*Samarium-153 (Quadramet)
*Selinexor (Xpovio)
*Selpercatinib (Retevmo)
*Selumetinib (Koselugo)
*Serplulimab (Hansizhuang)
*Sintilimab (Tyvyt)
*Sipuleucel-T (Provenge)
*Sirolimus protein-bound particles (Fyarro)
*Sonidegib (Odomzo)
*Sorafenib (Nexavar)
*Sotorasib (Lumakras)
*Stilbamidine
*Streptozocin (Zanosar)
*Strontium-89 (Metastron)
*Sugemalimab (Cejemly)
*Sunitinib (Sutent)
*Sunvozertinib (舒沃哲)
*Suramin (Antrypol)
==T==
*Tabelecleucel (Ebvallo)
*Tafasitamab (Monjuvi)
*Tagraxofusp (Elzonris)
*Talazoparib (Talzenna)
*Talimogene laherparepvec (Imlygic)
*Taloporfin (Laserphyrin)
*Talquetamab (Talvey)
*Tamibarotene (Amnoid)
*Tamoxifen (Nolvadex)
*Tarlatamab (Imdelltra) FDA approved 2024-05-16
*Tazemetostat (Tazverik)
*Tebentafusp (Kimmtrak)
*Teclistamab (Tecvayli)
*Tegafur and uracil (UFT)
*Tegafur, gimeracil, oteracil (Teysuno, S-1)
*Temoporfin (Foscan)
*Temozolomide (Temodar)
*Temsirolimus (Torisel)
*Teniposide (Vumon)
*Tepotinib (Tepmetko)
*Thalidomide (Thalomid)
*Thioguanine (Tabloid)
*Thiotepa (Tepadina)
*Thiotepa (Thioplex)
*Tirabrutinib (Velexbru)
*Tisagenlecleucel (Kymriah)
*Tisotumab vedotin (Tivdak)
*Topotecan (Hycamtin)
*Toremifene (Fareston)
*Toripalimab (Loqtorzi)
*Tositumomab and I-131 (Bexxar)
*Tovorafenib (Ojemda) FDA approved 2024-04-23
*Trabectedin (Yondelis)
*Trametinib (Mekinist)
*Trastuzumab (Herceptin)
**Trastuzumab-anns (Kanjinti)
**Trastuzumab-dkst (Ogivri)
**Trastuzumab-dttb (Ontruzant)
**Trastuzumab-herw (Herwenda)
**Trastuzumab-pkrb (Herzuma)
**Trastuzumab-qyyp (Trazimera)
**Trastuzumab-strf (Hercessi) FDA approved 2024-04-29
**Trastuzumab-tuzn (Tuznue)
**Trastuzumab-zerc (Zercepac)
**Trastuzumab and hyaluronidase (Herceptin Hylecta)
*Trastuzumab deruxtecan (Enhertu)
*Trastuzumab emtansine (Kadcyla)
*Tremelimumab (Imjudo)
*Treosulfan (Ovastat)
*Trifluridine and tipiracil (Lonsurf)
*Trimetrexate (Neutrexin)
*Triptorelin (Trelstar LA)
*Trofosfamide (Ixoten)
*Tucatinib (Tukysa)
*Tunlametinib (HL-085)
==U==
*Ublituximab (Briumvi)
==V==
*Valemetostat (Ezharmia)
*Valrubicin (Valstar)
*Vandetanib (Caprelsa)
*Vemurafenib (Zelboraf)
*Venetoclax (Venclexta)
*Vimseltinib (Romvimza) FDA approved 2025-02-14
*Vinblastine (Velban)
*Vincristine (Oncovin)
*Vindesine (Eldisine)
*Vinflunine (Javlor)
*Vinorelbine (Navelbine)
*Vismodegib (Erivedge)
*Vorasidenib (Voranigo) FDA approved 2024-08-06
*Vorinostat (Zolinza)
==Z==
*Zanidatamab (Zihera) FDA approved 2024-11-20
*Zanubrutinib (Brukinsa)
*Zenocutuzumab (Bizengri) FDA approved 2024-12-04
*Zimberelimab (Yu Duo)
*Ziv-aflibercept (Zaltrap)
*Zolbetuximab (Vyloy) FDA approved on 2024-10-18
*Zuberitamab (Anruixi)
=Discontinued antineoplastics=
This section contains drugs that have had at least one formal approval in any domain (FDA, EMA, etc), but are no longer on the market. Note that it is possible that these drugs continue to be available in some limited way, such as through compassionate use programs.
==A==
*Aminopterin
*Asparaginase (Elspar)
==B==
*BL22 immunotoxin (CAT-3888)
==D==
*Daunorubicin liposomal (DaunoXome)
*Denileukin diftitox (Ontak)
*Diethylstilbestrol (DES)
==E==
*Edrecolomab (Panorex)
*Ethinylestradiol
==F==
*Floxuridine (FUDR)
*Fluoxymesterone (Halotestin)
*Formestane (Lentaron)
==L==
*Levamisole (Ergamisol)
==M==
*Melphalan flufenamide (Pepaxto)
==O==
*Olaratumab (Lartruvo)
==P==
*Paclitaxel poliglumex (Opaxio)
*Plicamycin (Mithracin)
*Polyestradiol phosphate (Estradurin)
==S==
*Semustine (MeCCNU)
==T==
*Testolactone (Teslac)
*Triethylenemelamine (Tretamine)
==U==
*Umbralisib (Ukoniq)
*Uracil mustard
*Urethane
==V==
*Vincristine liposomal (Marqibo)
=Investigational antineoplastics=
This list is far from exhaustive. Drugs are included here generally once there are some encouraging preliminary results. Since is it very difficult to tell when a company has stopped development on a drug, this list may also include drugs that are no longer under investigation.
==A==
*Abexinostat (PCI-24781)
*Actinium Ac 225 lintuzumab (Actimab-A)
*Adavosertib (MK-1775)
*Adebrelimab (SHR-1316)
*Adenovirus-interferon-γ (TG-1042)
*Afuresertib (GSK-2110183)
*Agatolimod (PF-3512676)
*Alisertib (MLN-8237)
*Amatuximab (MORAb-009)
*Amonafide (Quinamed)
*Apocept (APG-101)
*Astuprotimut-R (GSK-1572932A)
==B==
*Barasertib (AZD-1152)
*Bavituximab (PGN-401)
*Befotertinib (D-0316)
*Belagenpumatucel-L (Lucanix)
*BE-CAR7
*BHQ-880
*Birtamimab (NEOD-001)
*Buparlisib (BKM-120)
==C==
*Camizestrant (AZD-9833)
*CARv3-TEAM-E T-cells
*Catumaxomab (Removab) in US clinical trials
*Cediranib (Recentin)
*Cixutumumab (IMC-A12)
*Coltuximab ravtansine (SAR-3419)
*Crenolanib (CP-868,596)
*Custirsen (OGX-011)
==D==
*Dalpiciclib (SHR-6390)
*Denintuzumab mafodotin (SGN-CD19A)
*Dinaciclib (SCH-727965)
*Divarasib (GDC-6036)
*Discodermolide (XAA-296)
*DMUC-5754A
*Dovitinib (TKI-258)
==E==
*Emepepimut-S (Stimuvax)
*Eluvixtamab (AMG-330)
*Entospletinib (GS-9973)
*Envonalkib (TQ-B3139)
*Epratuzumab (LymphoCide)
*Etirinotecan pegol (NKTR-102)
==F==
*Farletuzumab (MORAb-003)
*Figitumumab (CP-751,871)
*Filanesib (ARRY-520)
*Finotonlimab (SCT-I10A)
*FT-596
==G==
*G207
*Galeterone (TOK-001)
*Galunisertib (LY-2157299)
*Ganetespib (STA-9090)
*Ganitumab (AMG-479)
*GD2-CART01
*Gemcitabine elaidate (CP-4126)
*Giredestrant (GDC-9545)
*Glembatumumab vedotin (CDX-011)
*Guadecitabine (SGI-110)
==H==
*HER2 peptide vaccine (AE37)
*Hu5F9-G4
==I==
*Idasanutlin (RG-7388)
*IMA-901
*Indatuximab ravtansine (BT-062)
*Iodine I 131 apamistamab (Iomab-B)
*Ipatasertib (GDC-0068)
*IPH-2101
==J==
*JCAR015
==L==
*Lapuleucel-T (DN24-02)
*Lerociclib (GB-491)
*Lestaurtinib (CEP-701)
*Linifanib (ABT-869)
*Linsitinib (OSI-906)
*Lorvotuzumab mertansine (BB-10901)
*Lutetium-177-PSMA-617
*LY-3023414
==M==
*Magrolimab (Hu5F9-G4)
*Mapatumumab (HGS-ETR1)
*Masitinib (AB-1010)
*MCARH-109
*Mezigdomide (BMS-986348)
*Milataxel (TL-139)
*MK-2206
*Mocetinostat (MGCD-0103)
*Motesanib (AMG-706)
==N==
*Nolatrexed (Thymitaq)
==O==
*Oblimersen (Genasense)
*Olaptesed pegol (NOX-A12)
*Onartuzumab (MetMAb)
*Oprozomib (ONX-0912)
*Orteronel (TAK-700)
*Osocimab (BAY-1213790)
*Otlertuzumab (TRU-016)
==P==
*Patritumab deruxtecan (U3-1402)
*Perifosine (KRX-0401)
*Phosphomannopentaose sulfate (PI-88)
*Pictilisib (GDC-0941)
*Pidilizumab (CT-011)
*Pimitespib (TAS-116)
*Pinatuzumab vedotin (DCDT-2980S)
*Plinabulin (NPI-2358)
*Pracinostat (SB-939)
==Q==
*Quisinostat (JNJ-26481585)
==R==
*Rebimastat (BMS-275291)
*Refametinib (BAY-869766)
*Reovirus (Reolysin)
*Retaspimycin (IPI-504)
*Ricolinostat (ACY-1215)
*Ridaforolimus (AP-23573)
*Rilotumumab (AMG-102)
*Ripertamab (SCT-400)
*Rociletinib (CO-1686)
==S==
*Sapacitabine (CS-682)
*Sapanisertib (MLN-0128)
*Seliciclib (CYC-202)
*Semuloparin (AVE-5026)
*Socazolimab (ZKAB-001)
*Sovleplenib (HMPL-523)
*Spebrutinib (CC-292)
*Surufatinib (HMPL-012)
==T==
*Tabalumab (LY-2127399)
*Tasadenoturev (DNX-2401)
*Telisotuzumab vedotin (ABBV-399)
*Tertomotide (GV-1001)
*Tesetaxel (DJ-927)
*Tesevatinib (XL-647)
*Tigatuzumab (CS-1008)
*Tipifarnib (Zarnestra)
*Tirapazamine (Tirazone)
*Tislelizumab (Baizean)
*Tivantinib (ARQ-197)
*Tivozanib (AV-951)
*Tosedostat (CHR-2797)
*Trebananib (AMG-386)
*Tusamitamab ravtansine (SAR-408701)
==U==
*UCART19
==V==
*Vadastuximab talirine (SGN-CD33A)
*Vadimezan (AS-A404)
*Varlilumab (CDX-1127)
*Veliparib (ABT-888)
*Veltuzumab (hA20)
*Volasertib (BI-6727)
*Vorolanib (CM-082)
*Vosaroxin (SNS-595)
*Voxtalisib (XL-765)
==Z==
*Zandelisib (ME-401)
*Zinpentraxin alfa (PRM-151)
=Supportive and other medications=
This section contains supportive drugs that are either approved or investigational. Biosimilars are also indexed here, indented below their parent compound. Note that EMA biosimilar approvals do not include the four-letter suffix at this time, which we have added to distinguish the generic ingredient from the parent compound.
==A==
*Abciximab (ReoPro)
*Acetaminophen (Tylenol)
*Acetazolamide (Diamox)
*Acyclovir (Zovirax)
*ADAMTS13, recombinant (Adzynma)
*Alendronate (Fosamax)
*Alizapride (Litican)
*Allopurinol (Zyloprim)
*Alprazolam (Xanax)
*Aminocaproic acid (Amicar)
*Amoxicillin
*Anagrelide (Agrylin)
*Andexanet alfa (Andexxa)
*Anti-inhibitor coagulant complex (FEIBA NF)
*Antithrombin III, human (Thrombate III)
*Antithrombin III, recombinant (ATryn)
*Antithymocyte globulin, horse ATG (Atgam)
*Antithymocyte globulin, rabbit ATG (Grafalon)
*Antithymocyte globulin, rabbit ATG (Thymoglobulin)
*Apixaban (Eliquis)
*Aprepitant (Emend)
*Argatroban (Acova)
*Aripiprazole (Abilify)
*Ascorbic acid (Vitamin C)
*Aspirin
*Aspirin and dipyridamole (Aggrenox)
*Atropine (Atropen)
*Atovaquone (Mepron)
*Avatrombopag (Doptelet)
*Axatilimab (Niktimvo) FDA approved 2024-08-14
*Azathioprine (Imuran)
==B==
*Betibeglogene autotemcel (Zynteglo)
*Betrixaban (Bevyxxa)
*Bismuth subsalicylate (Pepto-Bismol)
*Bivalirudin (Angiomax)
==C==
*Cangrelor (Kengreal)
*Calcium phosphate rinse (Caphosol)
*Caspofungin (Cancidas)
*CD68-ET3-LV
*Cetirizine (Zyrtec)
*Chlorpheniramine (Chlor-Trimeton)
*Cilostazol (Pletal)
*Cimetidine (Tagamet)
*Ciprofloxacin (Cipro)
*Clarithromycin (Biaxin)
*Clemastine (Tavist)
*Clodronate (Bonefos)
*Clopidogrel (Plavix)
*Concizumab (Alhemo)
*Crizanlizumab (Adakveo)
*Cyanocobalamin (Vitamin B12)
*Cyclosporine
*Cytomegalovirus Immune Globulin (Cytogam)
==D==
*Dabigatran (Pradaxa)
*Dalteparin (Fragmin)
*Danazol (Danocrine)
*Danicopan (Voydeya) FDA approved 2024-03-29
*Dapsone (Aczone)
*Darbepoetin alfa (Aranesp)
*Deferasirox (Exjade)
*Deferasirox (Jadenu)
*Deferiprone (Ferriprox)
*Deferoxamine (Desferal)
*Defibrotide (Defitelio)
*Denosumab (Xgeva)
**Denosumab-bddz (Wyost)
*Desmopressin (DDAVP)
*Dexchlorpheniramine (Polaramine)
*Dexrazoxane (Zinecard)
*Diphenhydramine (Benadryl)
*Dipyridamole (Persantine)
*Docusate (Colace)
*Dolasetron (Anzemet)
*Domperidone (Motilium)
*Doxycycline
*Dronabinol (Marinol)
==E==
*Eculizumab (Soliris)
**Eculizumab-aaeb (Bekemv)
**Eculizumab-epys (Epysqli)
*Edoxaban (Savaysa)
*Efanesoctocog alfa (Altuviiio)
*Efbemalenograstim (Ryzneuta)
*Eflapegrastim (Rolvedon)
*Eltrombopag (Promacta)
*Emicizumab (Hemlibra)
*Enoxaparin (Lovenox)
**Enoxaparin-inhi (Inhixa)
*Epoetin alfa (Procrit)
**Epoetin alfa-epbx (Retacrit)
**Epoetin alfa-abse (Abseamed)
**Epoetin alfa-bino (Binocrit)
**Epoetin alfa-hexa (Epoetin Alfa Hexal)
*Epoetin theta (Biopoin)
*Epoetin zeta (Eprex)
**Epoetin zeta-reta (Retacrit)
**Epoetin zeta-sila (Silapo)
*Eptifibatide (Integrilin)
*Etranacogene dezaparvovec (Hemgenix)
*Exagamglogene autotemcel (Casgevy)
==F==
*Factor VIIa, recombinant (NovoSeven RT)
*Factor VIII, human
*Factor VIII, recombinant
*Factor IX, human
*Factor IX, recombinant
*Factor IX, recombinant, Fc fusion protein (Alprolix)
*Factor X, human (Coagadex)
*Factor XIII concentrate, human (Corifact)
*Famciclovir (Famvir)
*Famotidine (Pepcid)
*Ferric carboxymaltose (Injectafer)
*Ferric derisomaltose (Monoferric)
*Ferric gluconate (Ferrlecit)
*Ferrous sulfate (Feosol)
*Ferumoxytol (Feraheme)
*Fibrinogen concentrate, human (RiaSTAP)
*Fidanacogene elaparvovec (Beqvez) FDA approved 2024-04
*Filgrastim (Neupogen)
**Filgrastim-aafi (Nivestym)
**Filgrastim-ayow (Releuko)
**Filgrastim-txid (Nypozi)
**Filgrastim-sndz (Zarxio)
**Filgrastim-acco (Accofil)
**Filgrastim-hexa (Filgrastim Hexal)
**Filgrastim-gras (Grastofil)
**Filgrastim-rati (Ratiograstim)
**Filgrastim-teva (Tevagrastim)
*Finasteride (Proscar)
*Fitusiran (ALN-AT3SC)
*Fluconazole (Diflucan)
*Folic acid (Folate)
*Fondaparinux (Arixtra)
*Fosaprepitant (Emend for Injection)
*Fosnetupitant (Arokaris)
*Furosemide (Lasix)
==G==
*Glucarpidase (Voraxaze)
*Granisetron
==H==
*Haloperidol (Haldol)
*Hematopoetic progenitor cells, cord blood (Hemacord)
*Hympavzi (Marstacimab) FDA approved 2024-10-11
==I==
*Ibandronate (Boniva)
*Idarucizumab (Praxbind)
*Indomethacin (Indocin)
*Iptacopan (Fabhalta)
*Iron dextran (INFeD)
*Iron sucrose (Venofer)
*Itraconazole (Sporanox)
==L==
*Lactulose
*Lamivudine (Epivir)
*Lansoprazole (Prevacid)
*Lenograstim (Granocyte)
*Lepirudin (Refludan) discontinued
*Letermovir (Prevymis)
*Levofloxacin (Levaquin)
*L-glutamine (Endari)
*Lipefilgrastim (Lonquex)
*Loperamide (Imodium)
*Lorazepam (Ativan)
*Lovotibeglogene autotemcel (Lyfgenia)
*Lumrotatug (CM-313) NMPA approved in 2024
*Luspatercept (Reblozyl)
*Lusutrombopag (Mulpleta)
==M==
*Mannitol
*Mavorixafor (Xolremdi) FDA approved 2024-04-30
*Meperidine (Demerol)
*Mesna (Mesnex)
*Methyltesterone (Android)
*Metoclopramide (Reglan)
*Mitapivat (Pyrukynd)
*Motixafortide (Aphexda)
*Mycophenolate mofetil (CellCept)
==N==
*Nabilone (Cesamet)
*Netupitant and palonosetron (Akynzeo)
*Nonacog beta pegol (Refixia)
==O==
*Olanzapine (Zyprexa)
*Omeprazole (Prilosec)
*Omidubicel (Omisirge)
*Ondansetron (Zofran)
*Oprelvekin (Neumega)
==P==
*Palifermin (Kepivance)
*Palonosetron (Aloxi)
*Pamidronate (Aredia)
*Pantoprazole (Protonix)
*Pegfilgrastim (Neulasta)
**Pegfilgrastim-apgf (Nyvepria)
**Pegfilgrastim-bmez (Ziextenzo)
**Pegfilgrastim-cbqv (Udenyca)
**Pegfilgrastim-fpgk (Stimufend)
**Pegfilgrastim-jmdb (Fulphila)
**Pegfilgrastim-cegf (Cegfila)
**Pegfilgrastim-gras (Grasustek)
**Pegfilgrastim-pbbk (Fylnetra)
**Pegfilgrastim-pelg (Pelgraz)
**Pegfilgrastim-pelm (Pelmeg)
**Pegfilgrastim-stim (Stimufend)
*Penicillin V
*Pentamidine (Nebupent)
*Phenytoin (Dilantin)
*Phytonadione (Vitamin K)
*Plerixafor (Mozobil)
*Ponsegromab (GDF-15)
*Prasugrel (Effient)
*Pravastatin (Pravachol)
*Prochlorperazine (Compazine)
*Promethazine (Phenergan)
*Protamine sulfate
*Protein C, human (Ceprotin)
*Prothrombin Complex Concentrate, human
==Q==
*Quinine (Qualaquin)
==R==
*Rabeprazole (Aciphex)
*Raloxifene (Evista)
*Ramosetron (Iribo)
*Ranitidine (Zantac)
*Rasburicase (Elitek)
*Remestemcel-L (Ryoncil) FDA approved 2024-12-18
*Rho(D) immune globulin (RhoGAM)
*Rilzabrutinib (PRN-1008)
*Risedronate (Actonel)
*Rivaroxaban (Xarelto)
*Rolapitant (Varubi)
*Romiplostim (Nplate)
*Rusfertide (PTG-300)
==S==
*Sargramostim (Leukine)
*Scopolamine (Scopoderm)
*Sennosides (Senna)
*Siltuximab (Sylvant)
*Sirolimus (Rapamune)
*Sodium thiosulfate (Pedmark)
*Sutimlimab (Enjaymo)
==T==
*Tacrolimus (Prograf)
*Tbo-filgrastim (Granix)
*Telotristat (Xermelo)
*Ticagrelor (Brilinta)
*Ticlopidine (Ticlid)
*Tinzaparin (Innohep)
*Tirofiban (Aggrastat)
*Tocilizumab (Actemra)
**Tocilizumab-aazg (Tyenne)
**Tocilizumab-bavi (Tofidence)
*Tofacitinib (Xeljanz)
*Tranexamic acid (Cyklokapron)
*Trilaciclib (Cosela)
*Trimethoprim-Sulfamethoxazole (Bactrim DS)
*Tropisetron (Navoban)
==U==
*Unfractionated heparin (UFH)
*Uridine triacetate (Vistogard)
==V==
*Valacyclovir (Valtrex)
*Valganciclovir (Valcyte)
*Valoctocogene roxaparvovec (AAV5-hFVIII-SQ)
*Valproate (Depakote)
*Verbrinacogene setparvovec (FLT-180a)
*von Willebrand factor and factor VIII complex, human
*von Willebrand factor, recombinant
*Vonoprazan (Takecab)
*Vorapaxar (Zontivity)
*Voriconazole (Vfend)
==W==
*Warfarin (Coumadin)
==Z==
*Zoledronic acid (Zometa)
=Discontinued supportive and other medications=
==V==
*Voxelotor (Oxbryta)
=By Category=
Selecting a category here will take you to a new page listing all drugs in that category (note: drug categorization is an ongoing process so not all of these links are active or current).
==Drugs in a REMS program==
==Cytotoxic Chemotherapy==
*Alkylating agents
*Anthracyclines
*Antimetabolites
*DNA synthesis inhibitors
*Microtubule inhibitors
*Nitrogen mustards
*Nitrosureas
*Platinum agents
*Proteasome inhibitors
*Taxanes
*Topoisomerase inhibitors
*Vinca alkaloids
==Kinase inhibitors==
*AKT1 inhibitors
*ALK inhibitors
*Aurora kinase inhibitors
*AXL inhibitors
*Bcr-Abl inhibitors
*BRAF inhibitors
*BTK inhibitors
*CDK inhibitors
*EGFR inhibitors
*ERBB2 inhibitors
*ERBB4 inhibitors
*FGFR inhibitors
*FLT3 inhibitors
*IGFR inhibitors
*JAK inhibitors
*KIT inhibitors
*MEK inhibitors
*MET inhibitors
*mTOR inhibitors
*PDGFR inhibitors
*PI3K inhibitors
*PLK1 inhibitors
*RET inhibitors
*ROS1 inhibitors
*SRC inhibitors
*SYK inhibitors
*TEK inhibitors
*TRK inhibitors
*VEGF inhibitors
==Endocrine therapy==
*Antiandrogens
*Steroid synthesis inhibitors
*Androgen receptor inhibitors
*5 alpha-reductase inhibitors
*GnRH agonists
*GnRH antagonists
*Aromatase inhibitors
*Selective estrogen receptor modulators
*Steroids
*Somatostatin analogs
==Investigational and Discontinued==
*Investigational
*Discontinued
==Biologics==
*Antibody medications
*Antibody-drug conjugates
*Anti-HER2 medications
*IL-6 inhibitors
*Enzymes
*Immunotherapy
*Immunomodulatory drugs (IMiDs)
==Supportive Medications==
*Antibacterials
*Antidiarrheals
*Antifungals
*Antihistamines
*Antivirals
*Bisphosphonates
*Chemotherapy protective agents
*Emesis prevention
*PCP prophylaxis
*RANK ligand inhibitors
*Steroids
==Radioactive agents==
*Alpha emitters
*Radioimmunotherapy
==Benign Hematology Medications==
*Anticoagulants
**Direct thrombin inhibitors (DTI)
**Factor Xa inhibitors
**Heparins
**Low molecular weight heparins (LMWH)
**Vitamin K antagonists (VKA)
*Antiplatelet agents (APA)
**Phosphodiesterase inhibitors
**Cyclooxygenase inhibitors
**P2Y12 ADP inhibitors
*Hemostasis medications
**Coagulation factors
**Fibrinolysis inhibitors
**Vasopressin analogs
*Chelators
==Hematopoietic Growth Factors==
*Erythrocyte growth factors
*Granulocyte growth factors
*Megakaryocyte growth factors
==Miscellaneous==
*Drugs in a REMS program
*HDAC inhibitors
*Hypomethylating agents
*Retinoids
*WHO Essential Cancer Medicines
==Medications by Condition==
*Acute lymphocytic leukemia medications
*Acute myeloid leukemia medications
*Acute promyelocytic leukemia medications
*Anal cancer medications
*Anaplastic large cell lymphoma medications
*Bladder cancer medications
*Bone cancer medications
*Breast cancer medications
*Burkitt lymphoma medications
*Cancer of unknown primary medications
*Castleman disease medications
*Central nervous system (CNS) cancer medications
*Central nervous system (CNS) lymphoma medications
*Cervical cancer medications
*Chronic lymphocytic leukemia (CLL/SLL) medications
*Chronic myeloid leukemia (CML) medications
*Chronic myelomonocytic leukemia (CMML) medications
*Classical Hodgkin lymphoma medications
*Colon cancer medications
*Colorectal cancer (CRC) medications
*Cutaneous BCC medications
*Cutaneous SCC medications
*Cutaneous T-cell lymphoma medications
*Diffuse large B-cell lymphoma medications
*Endometrial cancer medications
*Esophageal cancer medications
*Essential thrombocythemia medications
*Extranodal NK/T-cell lymphoma, nasal type lymphoma medications
*Follicular lymphoma medications
*Gastric cancer medications
*Hairy cell leukemia medications
*Head and neck cancer medications
*Hepatobiliary cancer medications
*HIV-associated lymphoma medications
*Hodgkin lymphoma, nodular lymphocyte-predominant medications
*Immune thrombocytopenic purpura (ITP) medications
*Light-chain (AL) amyloidosis medications
*Mantle cell lymphoma medications
*Marginal zone lymphoma medications
*Mediastinal gray-zone lymphoma medications
*Melanoma medications
*Mesothelioma medications
*Multiple myeloma medications
*Myelodysplastic syndrome medications
*Myelofibrosis medications
*NK/T-cell lymphoma medications
*Non-small cell lung cancer medications
*Neuroendocrine tumor medications
*Ovarian cancer medications
*Pancreatic cancer medications
*Paroxysmal nocturnal hemoglobinuria (PNH) medications
*Penile cancer medications
*Peripheral T-cell lymphoma medications
*Plasma cell leukemia medications
*Polycythemia vera medications
*Primary mediastinal B-cell lymphoma medications
*Prostate cancer medications
*Rectal cancer medications
*Renal cell carcinoma medications
*Sarcoma medications
*Sickle cell anemia medications
*Small cell lung cancer medications
*T-cell lymphoma medications
*Testicular cancer medications
*Thymoma medications
*Thyroid cancer medications
*Transformed lymphoma medications
*Transplant medications
*Waldenström macroglobulinemia medications
==Medications by Route of Administration==
*Intraarterial (IA) medications
*Intracavitary medications
*Intramuscular (IM) medications
*Intrathecal (IT) medications
*Intravenous (IV) medications
*Intravesicular medications
*Oral (PO) medications
*Subcutaneous (SC) medications
==Medications by FDA Year of Approval==
*FDA approved in 1939
*FDA approved in 1941
*FDA approved in 1946
*FDA approved in 1949
*FDA approved in 1951
*FDA approved in 1952
*FDA approved in 1953
*FDA approved in 1954
*FDA approved in 1955
*FDA approved in 1956
*FDA approved in 1957
*FDA approved in 1958
*FDA approved in 1959
*FDA approved in 1962
*FDA approved in 1963
*FDA approved in 1964
*FDA approved in 1965
*FDA approved in 1966
*FDA approved in 1967
*FDA approved in 1968
*FDA approved in 1969
*FDA approved in 1970
*FDA approved in 1971
*FDA approved in 1973
*FDA approved in 1974
*FDA approved in 1975
*FDA approved in 1976
*FDA approved in 1977
*FDA approved in 1978
*FDA approved in 1979
*FDA approved in 1980
*FDA approved in 1981
*FDA approved in 1982
*FDA approved in 1983
*FDA approved in 1984
*FDA approved in 1985
*FDA approved in 1986
*FDA approved in 1987
*FDA approved in 1988
*FDA approved in 1989
*FDA approved in 1990
*FDA approved in 1991
*FDA approved in 1992
*FDA approved in 1993
*FDA approved in 1994
*FDA approved in 1995
*FDA approved in 1996
*FDA approved in 1997
*FDA approved in 1998
*FDA approved in 1999
*FDA approved in 2000
*FDA approved in 2001
*FDA approved in 2002
*FDA approved in 2003
*FDA approved in 2004
*FDA approved in 2005
*FDA approved in 2006
*FDA approved in 2007
*FDA approved in 2008
*FDA approved in 2009
*FDA approved in 2010
*FDA approved in 2011
*FDA approved in 2012
*FDA approved in 2013
*FDA approved in 2014
*FDA approved in 2015
*FDA approved in 2016
*FDA approved in 2017
*FDA approved in 2018
*FDA approved in 2019
*FDA approved in 2020
*FDA approved in 2021
*FDA approved in 2022
*FDA approved in 2023
*FDA approved in 2024
*FDA approved in 2025
=Interesting and Helpful Links=
*Antidepressants and other psychiatric medications in cancer care
*Antiemetic support
*Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline (2013)
*2016 Updated American Society of Clinical Oncology/Oncology Nursing Society (ASCO/ONS) Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology
*Chemotherapy Administration SequenceMancini R, Modlin J. Chemotherapy Administration Sequence: A Review of the Literature and Creation of a Sequencing Chart. J Hematol Oncol Pharm. 2011;1(1):17-25. link to original article - with chemotherapy sequencing chart
*The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy. EuroPMC
*CredibleMeds.org - lists of QT-prolonging drugs; requires free registration to see full list
*FDA drug shortages list
*ASHP drug shortages list - also includes information about discontinued drugs
*DailyMed - a comprehensive NLM portal to all FDA-approved drugs
*Drugs@FDA - the main portal into the FDA drug database
*The NCI Drug Dictionary - an extensive resource with most antineoplastics (approved and in clinical trials) listed
*In the Pipeline - a blog from a veteran of the pharmaceutical industry, Derek Lowe. General but much is cancer-relevant. The old home of this blog is no longer active.
*Steroid conversions
*Vesicant & irritant chemotherapy
*Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers
*CPIC Guidelines The Clinical Pharmacogenetics Implementation Consortium provides guidelines to help clinicians understand HOW available genetic test results should be used to optimize drug therapy
==References==
Category:General reference pages
Category:Clinical pharmacology